• SENSEX
    NIFTY 50
Healthcare

Strides Shasun experienced the toughest year. Will the woes come to an end?

Updated : June 26, 2018 03:16 PM IST

In November 2017, Strides Shasun announced its decision to sell its branded generic business in India to Eris Life for Rs 500 crore.
The institutional business as of FY17 was around 16 percent of the company’s sales.
Strides Shasun experienced the toughest year. Will the woes come to an end?

You May Also Like

Live TV
Advertisement